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ABSTRACT
Hydroxyethyl substituted amineplatinum(II) and (IV) complexes are an interesting class of platinum based
antitumour compounds due to their uncoordinated hydroxy groups. These hydroxy groups could play an
important role in the mode of action of such complexes with respect to their ability to act as donor or
acceptor for hydrogen bonds. Moreover, their chemistry in solution is of interest because it was found that
there is the possibility of an intramolecular attack to form ethanolatoamine chelated species which are
responsible for very stable monoadducts with 5’-GMP. Furthermore, there is the possibility of derivatisation
at the OH site to form a new series of platinum compounds which may be used for a carrier mediated
transport to tumour tissues. In this context a series of (N,N’-bis(2-hydroxyethyl)ethane-l,2-diamine)-
platinum(II) complexes has been synthesised. During purification of one of the platinum based compounds, it
was possible to isolate (SP-4-3)-R,S.(N,N’-bis(2-hydroxyethyl)ethane-l,2-diamine)malonatoplatinum(ll) and
to resolve the structure by single crystal structure analysis. Intra- and intermolecular hydrogen bonds have
been found which may explain the spontaneous crystallisation of the cis-R,S isomer and the stabilisation of
the boat conformation ofthe malonatoplatinum(II) six-membered ring.
INTRODUCTION
Since the discovery of cisplatin, (NH3)2PtCI2t’2j, as anticancer drug and its subsequent worldwide clinical
application for the treatment of different types of tumoursE31, the synthesis and investigation of platinum
compounds have become of interest. DNA is assumed to be the major target of a platinum based
chemotherapyt41. After DNA platination (clear preference for N7 of guanine) replication and transcription are
inhibited and apoptosis is induced. The application of cisplatin in therapy is limited by a variety of side
effects including dose dependent nephrotoxicityESI.
During the last decades, different strategies have been used to develop new platinum based anticancer
compounds. Central points are reduction of toxicity and side effects, to increase the activity spectrum and to
circumvent acquired cisplatin resistance of cells[6’7’8’9]. Therefore, thousands of platinum compounds have
been synthesised and tested with respect to their anticancer activity. Nearly 30 entered clinical trials, but only
carboplatin achieved worldwide approval and use. Based on a more detailed understanding of the mode of
action of cisplatin and analogues, a rational drug design has started resulting in new platinum compounds and
complexes which even violate the structure activity relationship" orally administrable platinum(IV)
compounds, di- and trinuclear complexes, sterically hindered Pt coordination compounds, trans complexes
and complexes with three nitrogen ligands.
In this context, we have synthesised mono- and bis(hydroxyethyl)substituted dianaineplatintm(ll/IV)I’’-’l
complexes which can be used for further derivatisation at the OH-group with respect to a carrier mediated
transport of the cytotoxic moiety. Furthermore, the complexes themselves are very interesting because of
their hydroxy-groups as a potential acceptor and/or donor for hydrogen bonds which could play an important
role in the binding of platinum complexes to DNA. In addition, such complexes recently have shown an
interesting behaviour in solution which resulted in very stable monoadducts with 5’-GMP ..41.
During the synthesis of a series of (N,N’-bis(2-hydroxyethyl)ethane-l,2-diamine)platinum(ll)complexes it
was possible to isolate (SP-4-3)-R,S-(N,N’-bis(2-hydroxyethyl)ethane-l,2-diamine)malonatoplatinuna(ll)
and to resolve its structure by single crystal structure analysis.
MATERIALS AND METHODS
Chemicals
All chemicals obtained from commercial suppliers were used as received and were of analytical grade. Water
was used bidistilled. The synthetic procedures were carried out in a light protected environment.
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NMR Spectra
tH-, 13C- and 2D NMR experiments were performed at 400.13 MHz (1H) and 100.61 MHz (13C) on a Bruker
DPX 400 spectrometer (UltraShield
TM Magnet) at 24C. The gradient selected 1H,H- and 13C,H shift
correlation experiments were performed using standard Bruker pulse programs.
X-Ray Structure Determination
The single crystal data were collected on a Nonius Kappa CCD diffractometer at room temperature. The
measured intensities were corrected for Lorentz- and polarisation effects. The crystal structure was
determined by direct methods (SHELXS-97, Sheldrick, 1997a)[15] and subsequent Fourier and difference
Fourier syntheses. Final structure parameters of the compound were obtained by full-matrix least squares
techniques on F (SHELXL-97, Sheldrick, 1997b)[161. X-ray structure analysis data are given in Table I.
Crystallographic data for the structure reported in this paper flare been deposited with the Cambridge
Crystallographic Data Center as supplementary publication no. CCDC 155444 [171.
Table I. X-Ray structure data of 1.
Molecular formula C9HzoN207Pt
Formula weight (gmol") 463.36
Spa.ce group P2(1)/c
a (A) 9.086(2)
b (.A) 9.267(2)
c (A) 15.960(3)
fl 92.18(3)
V(/3) 1342.9(5)
Formula units,per cell 4
Density (gcm’) 2.292
Radiation (Mo Ktz) (/) 0.71073
20max (o) 28.26
Reflns meas., Reflns unique, R(int) 5780, 2987, 0.0220
Independent data, Fo>2o(Fo) 2751
Variables 181
Largest difference peak and hole (e A"3) 4.088/-4.868
R1 [for Fo>2.o(2Fo)] 0.0534
wR2 [for all Fo 0.1341
GOF 1.144
Elemental Analyses
Elemental analyses were performed by the microanalytical laboratory at the University of Vienna.
Preparation of Platinum Complexes
The synthesis of the title compound (N,N’-bis(2-hydroxyethyl)ethane-l,2-diamine)malonatoplatinum(II)
(Scheme 1) starts from potassium tetrachloroplatinate(II)and N,N’-bis(2-hydroxyethyl)ethane-l,2-diamine.
After activation of the resulting platinum(II) complex with silver sulfate, the aquasulfato species was then
reacted with the in situ formed sodium salt of malonic acid. After addition of acetone and filtration the
solution was left at4C to crystallize.
Dichloro(N,N’-bis(2-hydroxyethyl)ethane-l,2-diamine)platinum(II). A solution of N,N’-bis(2-hydroxy-
ethyl)ethane-l,2-diamine (1.7916 g, 12.09 mmol) in 60 ml of ethanol was treated with K_PtCI4 (5.0176 g,
12.09 mmol). After addition of 115 ml of bidistilled water the pH was adjusted to 7 using diluted
hydrochloric acid and stirred at room temperature. The precipitates were collected over a period of 20 hours.
During this time the pH was kept constant at 7 using diluted NaOH. The yellow precipitates were washed
with water and dried over P4Ol0. Anal. Calc. for C6H6CI2N202Pt: C, 17.40; H, 3.89; N, 6.76; CI, 17.12; Pt,
47.10. Found: C, 17.45; H, 3.63; N, 6.62; CI, 17.45; Pt, 47.23. Yield, 78.5%.
Aqua(N,N’-bis(2-hydroxyethyl)ethane-l,2-diamine)sulfatoplatinum(II). An aqueous suspension of dichloro-
(N,N’-bis(2-hydroxyethyl)ethane-l,2-diamine)platinum(II) (2.7171 g, 6.56 mmol) was reacted with silver
sulfate (1.9431 g, 6.23 mmo!) at room temperature protected from light over night. The silver chloride
precipitate was removed by filtration and the filtrate was evaporated to dryness under reduced pressure. This
aqua species could be stored under nitrogen atmosphere over several days.
(N,N’-Bis(2-hydroxyethyl)ethane-l,2-diamine)malonatoplatinum(II). A solution of 0.1247 g of malonic acid
(1.20 retool) in 2.4 ml of 1.01 N NaOH was added to a solution of the aquasulfatoplatinum(II) complex
(0.5483 g, 1.20 mmol) in 5 ml bidistilled water and stirred for 90 min. at 50C and 16 hours at room
temperature. After addition of acetone and filtration the solution was left at 4C to crystallise. The crude
product was dried over P4Olo. Anal. Calc. for C9HtsNzO6Pt: C, 24.27; H, 4.07; N, 6.29. Found: C, 23.28; H,
3.75; N, 5.92. Yield, 8.9%.
lH NMR (D20): 2.5-3.1 (m, 8 H, H(a), H(b)), 3.49 (d, H, JH H=15 * Hz, H(d)), 3.55 (s, H(d)), 3.59 (d, H,
JH.H=15 Hz, H(d)), 3.65-3.9 (m, 4 H, H(c), 6.34 (rob, 2 H, NH’). 3C NMR (D:O): 47.94 (1 C, C(d)), 48.00",
53.96 (1 C, C(a)), 54.55", 54.65", 54.75 (2 C, C(b)), 57.67", 57.99 (2 C, C(c)), 178.35", 178.41 (2 C, C(e)),
{chemical shifts marked with a * belong to another isomer}.
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(SP-4-3)cis-RS-(NN-Bis(2hydrxyethyl)ethane-2-diamine)manatpatinum() 1. The crude product of
(N,N’-Bis(2-hydroxyethyl)ethane-l,2-diamine)malonatoplatinum(II) (colourless crystals) was dissolved in
water and left at4C for recrystallisation
KzPtCI + HOHNNHoH
#
HO
+ Ag2SO AgCI
HO HO
l"
h o l’--
malonic acid .+
Pt , Pt
/ NaOH /
N 0 N OHz
NO
Scheme 1. Synthesis of (N,N’-bis(2-hydroxyethyl)ethane-l,2-diamine)malonatoplatinum(II).
RESULTS AND DISCUSSION
There is no chiral atom in the free diamine ligand N,N’-bis(2-hydroxyethyl)ethane-l,2-diamine. After
coordination to the platinum(II) centre two chiral nitrogen atoms are produced resulting in the trans-R,R-,
trans-S,S- and cis-R,S isomerI181. Both trans forms are optical isomers (Figure 1).
HO
0 HO 0 0
// // ,,.o ,,,o hloo hi.. N 0 .......... s.. Pt "-’Pt .......... L’""N’SI
’’Pt .....
0 ;/ 0 0
.o o o
HO HO
Figure 1. trans-R,R-, trans-S,S- and cis-R,S isomer of dichloro(N,N’-bis(2-hydroxyethyl)ethane-l,2-
diamine)malonatoplatinum(II).
In the H- and 3C NMR spectra of the crude product of (N,N’-bis(2-hydroxyethyl)ethane-l,2-
diamine)malonatoplatinum(II) (Figure 2) which was obtained through addit’ion of acetone to the reaction
mixture, filtration and crystallisation at 4C, more than one isomer could be detected
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Figure 2. tH NMR spectrum of the crude product of (N,N’.-bis(2-hydroxyethyl)ethane-l,2-diamine)-
malonatoplatinum(l I).
In the region between 2.5-3.1 and 3.65-3.9 ppm where the methylene protons H(a), H(b) and H(c) resonate,
complicated multipletts can be observed which are not clearly resolved. In contrast, the H(d) protons between
3.45 and 3.65 ppm are isolated from the other resonances and can therefore be used to estimate the ratio of
the isomers. Two dubletts for the non-equivalent diastereotopic H(d) protons of the cis-R,S isomer at 3.49 and
3.59 ppm with a 2JH,H coupling of 15 Hz (typical value for such geminal methylene protons) can be detected.
A small singulett in the middle of the before mentioned dubletts at 3.55 which has no coupling to other
protons in.the H,IH shift correlation spectrum is also visible indicating the presence of one or both optical
transisomers (less than 10%).
In the 13C NMR spectrum two sets of signals can be observed: 5 major resonances at 47.94 (C(d)), 53.96
(C(a)), 54.75 (C(b)), 57.99 (C(c)), and 178.41 (C(e)) for the cis-R,S isomer and 5 small peaks at 48.00, 54.55,
54.65, 57.67 and 178.35 for one or both trans isomers.
After recrystallisation of the crude product at 4C the cis-R,S isomer (SP-4-3)-cis-R,S-(N,N’-bis(2-hydroxy-
ethyl)ethane-l,2-diamine)malonatoplatinum(II) 1 spontaneously crystallised (Figure 3) out of aq.ueous
solution.
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Figure 3. Structure of (SP-4-3)-is-RS-(NN-bis(2-hydrxyethy)ethane-2-diamine)manatpatinum(II)
1 in the crystal. Selected distances (A) and angles (o): Pt-O1 2.034(5), Pt-O2 2.035(5), Pt-N2 2.037(6), Pt-N1
2.044(6), O1-C5 1.289(8), O2-C6 1.286(8), O3-C6 1.231(8), O5-C5 1.220(8), C3-C5 1.510(10), C3-C6
1.529(10), C1-C2 1.515(11); O1-Pt-O2 89.4(2), O1-Pt-N2 91.9(3), O2-Pt-Nl 93.4(3), N2-Pt-NI 85.4(3), 02-
Pt-N2 178.24(18), O1-Pt-N1 177.24(19), C5-O1-Pt 120.6(4), C6-O2-Pt 120.0(4), C5-C3-C6 114.1(6), 03-
C6-O2 122.8(6), O5-C5-O1 121.8(6), O5-C5-C3 119.9(6), O1-C5-C3 118.2(5), O3-C6-O2 122.8(6), O3-C6-
C3 1.18.4(6), CI-N1-Pt 108.5(4), C2-N2-Pt 105.5(4), N2-C2-C1 107.7(5), N1-CI-C2 109.1(5).
The O and N atoms are arranged in a square planar manner around the platinum(II) centre. The angular sum
is 360.1 with angles of 85.4(3) N2-Pt-N1, 89.4(2) O1-Pt-O2, 91.9(3) O1-Pt-N2 and 93.4(3) O1-Pt-N2,
respectively. The angular sums in the ethane-l,2-diamineplatinum(II) chelate (five-membered ring) is 516.2,
whereas in the six-membered malonatoplatinum(II) ring it is 681.1. The Pt-O and Pt-N distances (Pt-Ol
2.034(5) A, Pt-O2 2.035(5) A, Pt-N1 2.044(6) A, Pt-N2 2.037(6) A) are in the normal range of
aminecarboxylatoplatinum(II) complexes.
Figure 4. Structure fragment of in the crystal showing the boat- and envelope conformation of the two
platina rings.
The Pt-N 1-C1-C2-N2 ring adopts an envelope conformation (Figure 4) with dihedral angles of 3.20, 30.50,
52.57, 47.60 and 24.48 at Pt-Nl, N1-C1, C1-C2, C2-N2, and N2-Pt, respectively. In the Pt-O1-C5-C3-C6-
02 ring the dihedral angles at Pt-O1, O1-CS, C5-C3, C3-C6, C6-O2 and O2-Pt are found to be 42.25, 5.99,
50.52, 57.62, 5.20 and 35.67. The values found are in good agreement with values expected for these
conformations. In comparison, the dihedral angles in cyclopentane in the envelope conformation are 0, 25,
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40, 40 and 25 (half chair conformation: 13, 34, 42, 34 and 13) and in cyclohexane in the boat conformation
54, 0, 54, 54, 0 and 54 (chair conformation: 56).
The structure of is stabilised by one intramolecular and four intermolecular hydrogen bonds in the crystal
(Figure 3 and 5).
Figure 5. Structure fragment of 1 in the crystal showing the intermolecular donor acceptor contacts between
N and O and the very weak C-H O interaction.
The intramolecular donor acceptor contact between 06 and O1 is 2.823(7) A, (O6-H O1). Both oxygen
atoms of the keto groups (03 and 05) are involved in a hydrogen bond network to the water molecule in the
crystal (O1W-O3, 2.742(7) ,, O1W-H 03 and O1W-OS, 2.831 (7) A, O1W-H 05) and to the nitrogen
atoms N1 and N2 of the neighbouring ethane-l,2-diamine units (N1-O3, 3.033(8)/, N1-H 03 and N2-O5,
2.904(8) A, N2-H 05). These interactions seem on the one hand to stabilise the boat conformation of the
malonatoplatinum(II) conformation. On the other hand the spontaneous crystallisation of the cis-R,S isomer
could be explained by the intra- and intermolecular hydrogen bonds as possible driving force.
Moreover, a nearly linear arrangement of C3-H3 04 could be found with an angle of 172.17. The distance
between C3 and 04 is found to be 3.532(8) A which is not in the range of C-H O hydrogen bonds (donor
acceptor contacts around 3.2 A) but may indicate a very weak attractive interaction further stabilising the
structure of found in the crystal.
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